1. World Health Organization. Dementia. Available athttps://www.who.int/health-topics/dementia#tab=tab_2. Last accessed August 2, 2024.
2. Alzheimer's Association. 2024 Alzheimer's Disease Facts and Figures. Available at https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf. Last accessed July 31, 2024.
3. Alzheimer's Association. Press Release: New Alzheimer's Association Report Finds Patient-Physician Communication About Cognitive Concerns Needs Improvement as New Treatments Become Available. March 15, 2023. Available at https://www.alz.org/news/2023/facts-figures-report-patient-doctor-communication. Last accessed July 31, 2024.
4. Alzheimer's Association. 2023 Alzheimer's Disease Facts and Figures Report: At a Glance Statistics. Available at https://alz.org/media/Documents/Facts-And-Figures-2023-At-A-Glance-Stats-Fact-Sheet.pdf. Last accessed July 31, 2024.
5. Zhou S, Chen S, Liu X, Zhang Y, Zhao M, Li W. Physician activity improves cognition and activities of daily living in adults with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials. Int J Environ Res Public Health. 2022;19(1216):1-16.
6. Ophey A, Wolfsgruber S, Roeske S, et al. Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: implications for neuropsychological assessments. Alzheimers Dement (Amst). 2021;13(1):e12223.
7. Alzheimer's Association. Cognitive Screening and Assessment. Available at https://www.alz.org/professionals/health-systems-medical-professionals/cognitive-assessment. Last accessed August 13, 2024.
8. Michael J. Fox Foundation. Exercise. Available at https://www.michaeljfox.org/news/exercise. Last accessed August 13, 2024.
9. Johns Hopkins Medicine. Johns Hopkins in Health: The Richman Family Precision Medicine Center of Excellence in Alzheimer's Disease. Available at https://www.hopkinsmedicine.org/inhealth/precision-medicine-centers/alzheimers/index.html. Last accessed August 2, 2024.
10. Mayo Clinic. Alzheimer's Disease: Symptoms & Causes. Available at https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447. Last accessed August 2, 2024.
11. Alzheimer's Association. Stages of Alzheimer's. Available at https://www.alz.org/alzheimers-dementia/stages. Last accessed August 13, 2024.
12. National Institute on Aging. What Is Alzheimer's Disease? Available at https://www.nia.nih.gov/health/what-alzheimers-disease. Last accessed August 2, 2024.
13. Villemagne VL, Burnham S, Bourgeat P, et al. Amyloid ß deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol. 2013;12(4):357-367.
14. National Institute on Aging. Memory Problems, Forgetfulness, and Aging. Available at https://www.nia.nih.gov/health/memory-loss-and-forgetfulness/memory-problems-forgetfulness-and-aging. Last accessed August 2, 2024.
15. Ismail Z, Rajji TK, Shulman KI. Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry. 2018;33(1):2-21.
16. Tariq SH, Tumosa N, Chibnall JT, Perry MH III, Morley JE. Comparison of the Saint Louis University mental status examination and the Mini-Mental State Examination for detecting dementia and mild neurocognitive disorder: a pilot study. Am J Geriatr Psychiatry. 2006;14(11):900-910.
17. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699.
18. Shulman KI, Gold DP, Cohen CA, Zucchero CA. Clock-drawing and dementia in the community: a longitudinal study. Int J Geriatr Psychiatry. 1993;8:487-496.
19. American Medical Association. Practice Management: CPT. Available at https://www.ama-assn.org/practice-management/cpt. Last accessed August 13, 2024.
20. Centers for Medicare and Medicaid Services. Cognitive Assessment & Care Plan Services. Available at https://www.cms.gov/medicare/payment/fee-schedules/physician/cognitive-assessment. Last accessed August 2, 2024.
21. U.S. Food and Drug Administration. FDA Grants Accelerated Approval for Alzheimer's Disease Treatment. Available at https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-disease-treatment. Last accessed August 8, 2024.
22. Fazio S, Pace D, Flinner J, Kallmyer B. The fundamentals of person-centered care for individuals with dementia. Gerontologist. 2018;58(Suppl 1);S10-S19.
23. Esandi N, Nolan M, Canga-Armayor N, Pardavila-Belio MI, Canga-Armayor A. Family dynamics and the Alzheimer's disease experience. J Fam Nurs. 2021;27(2):124-135.
24. Alzheimer's Association. Communication and Alzheimer's. Available at https://www.alz.org/help-support/caregiving/daily-care/communications. Last accessed July 31, 2024.
25. Gaugler JE, Marx KA, Dabelko-Schoeny H, et al. Novel interventions for people with dementia and their caregivers: results from the National Institute on Aging IMPACT Collaboratory. J Am Geriatr Soc. 2022;70(S1):S117-S129.
26. Cummings J, Lee G, Zhong K, Fonseca J, Taghva K. Alzheimer's disease drug development pipeline: 2021. Alzheimers Dement (N Y). 2021;7(1):e12179.
27. U.S. Food and Drug Administration. FDA Grants Accelerated Approval for Alzheimer's Drug. Available at https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug. Last accessed August 8, 2024.
28. Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413-446.
29. Alzheimer's Association. Aducanumab to Be Discontinued as an Alzheimer's Treatment. Available at https://www.alz.org/alzheimers-dementia/treatments/aducanumab. Last accessed August 13, 2024.
1. American Psychological Association. Guidelines for the Evaluation of Dementia and Age-Related Cognitive Change. Washington, DC: American Psychological Association; 2021. Available at https://www.apa.org/practice/guidelines/guidelines-dementia-age-related-cognitive-change.pdf. Last accessed August 21, 2024.
2. Schmidt R, Hofer E, Bouwman FH, et al. EFNS-ENS/EAN guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease. Eur J Neurol. 2015;22(6):889-898. Available at https://onlinelibrary.wiley.com/doi/full/10.1111/ene.12707. Last accessed August 21, 2024.
Mention of commercial products does not indicate endorsement.